Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0P2ZY
|
||||
Former ID |
DNCL002226
|
||||
Drug Name |
INNO-305
|
||||
Indication | Acute myeloid leukemia; Lung cancer [ICD9: 205, 162; ICD10:C92.0, C33-C34] | Phase 1 | [548250] | ||
Company |
CytRx
|
||||
Target and Pathway | |||||
Target(s) | Wilms' tumor protein | Target Info | Modulator | [548249] | |
KEGG Pathway | Transcriptional misregulation in cancer | ||||
NetPath Pathway | FSH Signaling Pathway | ||||
IL5 Signaling Pathway | |||||
Pathway Interaction Database | p73 transcription factor network | ||||
Regulation of Telomerase | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.